CETTA, ILARIA
CETTA, ILARIA
Facoltà di Medicina e Chirurgia
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study
2022-01-01 Cetta, Ilaria; Messina, Roberta; Zanandrea, Laura; Colombo, Bruno; Filippi, Massimo
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x)
2022-01-01 Barbanti, P.; Egeo, G.; Aurilia, C.; D'Onofrio, F.; Albanese, M.; Cetta, I.; Di Fiore, P.; Zucco, M.; Filippi, M.; Bono, F.; Altamura, C.; Proietti, S.; Bonassi, S.; Vernieri, F.
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x)
2022-01-01 Barbanti, P.; Egeo, G.; Aurilia, C.; D'Onofrio, F.; Albanese, M.; Cetta, I.; Di Fiore, P.; Zucco, M.; Filippi, M.; Bono, F.; Altamura, C.; Proietti, S.; Bonassi, S.; Vernieri, F.
Imaging the brain and vascular reactions to headache treatments: a systematic review
2023-01-01 Messina, R.; Christensen, R. H.; Cetta, I.; Ashina, M.; Filippi, M.
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report
2022-01-01 Cetta, I.; Messina, R.; Colombo, B.; Filippi, M.
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
2023-01-01 Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; SanRaf MS Study, Group; Preziosa, Paolo; Paolo, Moiola; Lucia, ; Filippi, Massimo
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
2023-01-01 Vernieri, Fabrizio; Brunelli, Nicoletta; Guerzoni, Simona; Iannone, Luigi Francesco; Baraldi, Carlo; Rao, Renata; Schiano di Cola, Francesca; Ornello, Raffaele; Cevoli, Sabina; Lovati, Carlo; Albanese, Maria; Perrotta, Armando; Cetta, Ilaria; Rossi, Sergio Soeren; Taranta, Valentina; Filippi, Massimo; Geppetti, Pierangelo; Sacco, Simona; Altamura, Claudia
Stress in paediatric migraine: a trigger factor?
2020-01-01 Colombo, B.; Cetta, I.; Messina, R.; Filippi, M.
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
2021-01-01 Giordano, Antonino; Cetta, Ilaria; Orrico, Mario; Montini, Federico; Sangalli, Francesca; Colombo, Bruno; Filippi, Massimo; Martinelli, Vittorio
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
2023-01-01 Filippi, M.; Messina, R.; Bartezaghi, M.; Cetta, I.; Colombo, B.; Grazzi, L.; Martinelli, D.; Ornello, R.; Pichiecchio, A.; Raimondi, D.; Russo, A.; Sacco, S.; Splendiani, A.; Tassorelli, C.; Turrini, R.; Valsasina, P.; Rocca, M. A.; Bruno, F.; Campanella, A.; Caponnetto, V.; Dall’Occhio, L.; Silvestro, M.; Vuotto, R.
Tracking the evolution of non-headache symptoms through the migraine attack
2022-01-01 Messina, Roberta; Cetta, Ilaria; Colombo, Bruno; Filippi, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study | 1-gen-2022 | Cetta, Ilaria; Messina, Roberta; Zanandrea, Laura; Colombo, Bruno; Filippi, Massimo | |
| Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) | 1-gen-2022 | Barbanti, P.; Egeo, G.; Aurilia, C.; D'Onofrio, F.; Albanese, M.; Cetta, I.; Di Fiore, P.; Zucco, M.; Filippi, M.; Bono, F.; Altamura, C.; Proietti, S.; Bonassi, S.; Vernieri, F. | |
| Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x) | 1-gen-2022 | Barbanti, P.; Egeo, G.; Aurilia, C.; D'Onofrio, F.; Albanese, M.; Cetta, I.; Di Fiore, P.; Zucco, M.; Filippi, M.; Bono, F.; Altamura, C.; Proietti, S.; Bonassi, S.; Vernieri, F. | |
| Imaging the brain and vascular reactions to headache treatments: a systematic review | 1-gen-2023 | Messina, R.; Christensen, R. H.; Cetta, I.; Ashina, M.; Filippi, M. | |
| Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report | 1-gen-2022 | Cetta, I.; Messina, R.; Colombo, B.; Filippi, M. | |
| Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience | 1-gen-2023 | Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; SanRaf MS Study, Group; Preziosa, Paolo; Paolo, Moiola; Lucia, ; Filippi, Massimo | |
| Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study | 1-gen-2023 | Vernieri, Fabrizio; Brunelli, Nicoletta; Guerzoni, Simona; Iannone, Luigi Francesco; Baraldi, Carlo; Rao, Renata; Schiano di Cola, Francesca; Ornello, Raffaele; Cevoli, Sabina; Lovati, Carlo; Albanese, Maria; Perrotta, Armando; Cetta, Ilaria; Rossi, Sergio Soeren; Taranta, Valentina; Filippi, Massimo; Geppetti, Pierangelo; Sacco, Simona; Altamura, Claudia | |
| Stress in paediatric migraine: a trigger factor? | 1-gen-2020 | Colombo, B.; Cetta, I.; Messina, R.; Filippi, M. | |
| Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report | 1-gen-2021 | Giordano, Antonino; Cetta, Ilaria; Orrico, Mario; Montini, Federico; Sangalli, Francesca; Colombo, Bruno; Filippi, Massimo; Martinelli, Vittorio | |
| The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) | 1-gen-2023 | Filippi, M.; Messina, R.; Bartezaghi, M.; Cetta, I.; Colombo, B.; Grazzi, L.; Martinelli, D.; Ornello, R.; Pichiecchio, A.; Raimondi, D.; Russo, A.; Sacco, S.; Splendiani, A.; Tassorelli, C.; Turrini, R.; Valsasina, P.; Rocca, M. A.; Bruno, F.; Campanella, A.; Caponnetto, V.; Dall’Occhio, L.; Silvestro, M.; Vuotto, R. | |
| Tracking the evolution of non-headache symptoms through the migraine attack | 1-gen-2022 | Messina, Roberta; Cetta, Ilaria; Colombo, Bruno; Filippi, Massimo |